CDSCO UID MFG/IVD/2023/000103_d0e2d72b47a5b354b05c46a4e3bb76cf_6e2a3106e03e6f0dbcf2fde66e905b68

FILARIASIS Antibody Test

Genovik Biotech Pvt. Ltd.·Device Class Class B·India CDSCO
Registration details
UID
MFG/IVD/2023/000103_d0e2d72b47a5b354b05c46a4e3bb76cf_6e2a3106e03e6f0dbcf2fde66e905b68
Device class
Class B
Approving authority
Rajasthan
Product information
The Filariasis Antibody Test is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG and IgM antibodies to lymphatic filarial parasites ##PLACEHOLDER_0## in human serum, plasma or whole blood. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with lymphatic filarial parasites
Other products from Genovik Biotech Pvt. Ltd.
Products from the same license holder (10 products)
Total Triiodothyronine Test
Brand: RF-IgM
Class B
LEPTOSPIRA Antibody Test
Class B
Immunoglobulin E Antibody Test
Brand: RF-IgM
Class B
Total Immunoglobulin E Test
Brand: RF-IgM
Class B
Urinary Microalbumin Test
Brand: RF-IgM
Class B
ESTRADIOL Test
Brand: RF-IgM
Class B
Anti-Cyclic Citrullinated Peptide Test
Brand: RF-IgM
Class B
Free Thyroxine Test
Brand: RF-IgM
Class B
Glycosylated hemoglobin Test
Brand: RF-IgM
Class B
Free Triiodothyronine Test
Brand: RF-IgM
Class B
About this record

FILARIASIS Antibody Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000103_d0e2d72b47a5b354b05c46a4e3bb76cf_6e2a3106e03e6f0dbcf2fde66e905b68. The license holder is Genovik Biotech Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Rajasthan.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.